|
1
|
Inoue Y and Kusunoki M: Advances and
directions in chemotherapy using implantable port systems for
colorectal cancer: A historical review. Surg Today. 44:1406–1414.
2014. View Article : Google Scholar :
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hewitson P, Glasziou P, Watson E, Towler B
and Irwig L: Cochrane systematic review of colorectal cancer
screening using the fecal occult blood test (hemoccult): An update.
Am J Gastroenterol. 103:1541–1549. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ochiai H, Ohishi T, Osumi K, Tokuyama J,
Urakami H, Seki S, Shimada A, Matsui A, Isobe Y, Murata Y, et al:
Reevaluation of serum p53 antibody as a tumor marker in colorectal
cancer patients. Surg Today. 42:164–168. 2012. View Article : Google Scholar
|
|
5
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fabbri M: miRNAs as molecular biomarkers
of cancer. Expert Rev Mol Diagn. 10:435–444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ng EK, Chong WW, Jin H, Lam EK, Shin VY,
Yu J, Poon TC, Ng SS and Sung JJ: Differential expression of
microRNAs in plasma of patients with colorectal cancer: A potential
marker for colorectal cancer screening. Gut. 58:1375–1381. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kanaan Z, Rai SN, Eichenberger MR, Roberts
H, Keskey B, Pan J and Galandiuk S: Plasma miR-21: A potential
diagnostic marker of colorectal cancer. Ann Surg. 256:544–551.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nonaka R, Nishimura J, Kagawa Y, Osawa H,
Hasegawa J, Murata K, Okamura S, Ota H, Uemura M, Hata T, et al:
Circulating miR-199a-3p as a novel serum biomarker for colorectal
cancer. Oncol Rep. 32:2354–2358. 2014.PubMed/NCBI
|
|
13
|
Toiyama Y, Takahashi M, Hur K, Nagasaka T,
Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A: Serum miR-21
as a diagnostic and prognostic biomarker in colorectal cancer. J
Natl Cancer Inst. 105:849–859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen HY, Lin YM, Chung HC, Lang YD, Lin
CJ, Huang J, Wang WC, Lin FM, Chen Z, Huang HD, et al: miR-103/107
promote metastasis of colorectal cancer by targeting the metastasis
suppressors DAPK and KLF4. Cancer Res. 72:3631–3641. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Kuang Y, Shen X, Zhou H, Chen Y,
Han Y, Yuan B, Zhou J, Zhao H, Zhi Q and Xue X: Evaluation of
miR-720 prognostic significance in patients with colorectal cancer.
Tumour Biol. 36:719–727. 2015. View Article : Google Scholar
|
|
16
|
Yang IP, Tsai HL, Huang CW, Huang MY, Hou
MF, Juo SH and Wang JY: The functional significance of microRNA-29c
in patients with colorectal cancer: A potential circulating
biomarker for predicting early relapse. PLoS One. 8:e668422013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Heegaard NH, Schetter AJ, Welsh JA, Yoneda
M, Bowman ED and Harris CC: Circulating micro-RNA expression
profiles in early stage nonsmall cell lung cancer. Int J Cancer.
130:1378–1386. 2012. View Article : Google Scholar :
|
|
18
|
Zhang Y, Liu D, Chen X, Li J, Li L, Bian
Z, Sun F, Lu J, Yin Y, Cai X, et al: Secreted monocytic miR-150
enhances targeted endothelial cell migration. Mol Cell. 39:133–144.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng H, Zhang L, Cogdell DE, Zheng H,
Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR and Zhang W:
Circulating plasma MiR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
